Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,049 public trials 570 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma

NCT00049673

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 18 locations
View Trial Details
Completed

Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients

NCT01346787

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • IRCCS CROB UOC di Ematologia e trapianto cellule staminali Ospedale Oncologico Regionale Rionero in Vulture, PZ, Italy
  • azienda ospedaliero-universitaria umberto I Clinica di Ematologia Ancona, Italy
  • Policlinico S. Orsola Istituto di Ematologia e Oncologia Medica Bologna, Italy
  • Ospedale Ferrarotto_Reparto di Ematologia Catania, Italy
View all 13 locations
View Trial Details
Completed

Role of Osteocytes in Myeloma Bone Disease

NCT02212262

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • VA Roudebush Medical Center Indianapolis, Indiana, United States
View Trial Details
Completed

High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma

NCT02597062

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada
  • QEII Health Sciences Centre Halifax, Nova Scotia, Canada
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
View Trial Details

Related conditions